Clinical Trial

Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to investigate the disease progression trends and risk factors of common AIDS-related tumors, including Kaposi sarcoma, lymphoma, lung cancer, and et al., among people living with HIV. By analyzing clinical data, the researchers hope to better understand how these cancers develop in HIV-infected patients and identify factors that may increase the risk. The findings may help improve early detection and treatment strategies for these cancers in the HIV population. This is an observational study, meaning participants will receive their usual medical care while researchers collect and analyze their health information. No experimental treatments will be given as part of this study.
Trial Details
NCT Number NCT07696169
Lead Sponsor Shenzhen Third People's Hospital
Collaborators: Chongqing Public Health Medical Center, Xinjiang Uygur Autonomous Region Infectious Disease Hospital, Beijing Ditan Hospital, Fudan University, Guangzhou Eighth People's Hospital, Guangzhou Medical University., Nanfang Hospital, Southern Medical University
Conditions HIV (Human Immunodeficiency Virus), AIDS, Kaposi Sarcoma (KS), Lymphoma, AIDS-Related Malignancy, Lung Cancer in the HIV Patient, Cervical Cancer, Anal Cancer +2 more
Enrollment 1,000 participants
Start Date 2026-07
Primary Completion 2029-02 (estimated)
Study Completion 2029-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-10